Abstract
Objectives This preliminary study identified a missense variant in ACTG1 (NM_001614.5) in a family with autosomal dominant non-syndromic hearing loss (ADNSHL). The responsiveness of the electrically-stimulated cochlear nerve (CN) in two implanted participants with this missense change was also evaluated and reported.
Design Genetic testing was done using a custom capture panel (MiamiOtoGenes) and whole exome sequencing. The responsiveness of the electrically-stimulated CN was evaluated in two members of this family (G1 and G4) using the electrically evoked compound action potential (eCAP). eCAP results from these two participants were compared with those measured three implanted patient populations: children with cochlear nerve deficiency, children with idiopathic hearing loss and normal-sized cochlear nerves, and postligually deafened adults.
Results Sequencing of ACTG1 identified a missense c.737A>T (p. Gln246Leu) variant in ACTG1 (NM_001614.5) which is most likely the genetic cause of ADNSHL in this family. eCAP results measured in these two participants showed substantial variations.
Conclusion The missense c.737A>T (p. Gln246Leu) variant in ACTG1 (NM_001614.5) co-segregated with hearing loss in this family. The responsiveness of the electrically-stimulated CN can vary among patients with the same genetic variants, which suggests the importance of evaluating the functional status of the CN for individual CI patients.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the R01 grants (R01 DC005575 and R01 DC012115) from the National Institutes of Health/National Institute on Deafness and Other Communication Disorders awarded to Xue Zhong Liu, as well as the R01 grant (R01DC016038) from the National Institute on Deafness and Other Communication Disorders and the National Institute of General Medical Sciences awarded to Shuman He.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Biomedical Institutional Review Board of The Ohio State University gave ethical approval for this work (2017H0131).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Email addresses: Yi.Yuan{at}osumc.edu; dyan{at}med.miami.edu; Jeffrey.Skidmore{at}osumc.edu; chapagap{at}fiu.edu; x.liu1{at}med.miami.edu; Shuman.He{at}osumc.edu
Declarations of Interest: None.
Source of Funding: This work was supported by the R01 grants (R01 DC005575 and R01 DC012115) from the National Institutes of Health/National Institute on Deafness and Other Communication Disorders awarded to Xue Zhong Liu, as well as the R01 grant (R01DC016038) from the National Institute on Deafness and Other Communication Disorders and the National Institute of General Medical Sciences awarded to Shuman He.
Data Availability
Please contact the corresponding authors to discuss access to the data presented in this study.
